J
Jeffrey L. Lennox
Researcher at Emory University
Publications - 95
Citations - 7717
Jeffrey L. Lennox is an academic researcher from Emory University. The author has contributed to research in topics: Viral load & Raltegravir. The author has an hindex of 42, co-authored 94 publications receiving 7236 citations. Previous affiliations of Jeffrey L. Lennox include Grady Memorial Hospital.
Papers
More filters
Journal ArticleDOI
A Study of Discontinuing Maintenance Therapy in Human Immunodeficiency Virus–Infected Subjects with Disseminated Mycobacterium avium Complex: AIDS Clinical Trial Group 393 Study Team
Judith A. Aberg,Paige L. Williams,Tun Liu,Howard M. Lederman,Richard Hafner,Francesca J. Torriani,Jeffrey L. Lennox,Michael P. Dubé,Rob Roy MacGregor,Judith S. Currier +9 more
TL;DR: Withdrawal of anti-MAC therapy appears to be safe in patients who have been treated with a macrolide-based regimen for at least 1 year and have an immunologic response on HAART.
Journal ArticleDOI
Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy
TL;DR: In this large cohort study, nosocomial/health care-associated infections were common in ICU patients with HIV and severe sepsis and hospital mortality was associated with acute illness severity, but not clearly associated with variables related to HIV infection.
Journal ArticleDOI
Diversity, Divergence, and Evolution of Cell-Free Human Immunodeficiency Virus Type 1 in Vaginal Secretions and Blood of Chronically Infected Women: Associations with Immune Status
Sharon T. Sullivan,Usha Mandava,Tammy Evans-Strickfaden,Jeffrey L. Lennox,Tedd V. Ellerbrock,Clyde E. Hart +5 more
TL;DR: Diversity, divergence, and evolution of cell-free HIV-1 in VS can be different from that in BP, and dynamics between their respective quasispecies are associated with changes in CD4+ cell levels.
Journal ArticleDOI
High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States.
Natasha S. Hochberg,Ruth N. Moro,Anandi N. Sheth,Susan P. Montgomery,Frank Steurer,Isabel McAuliffe,Yun F. Wang,Yun F. Wang,Wendy S. Armstrong,Hilda N. Rivera,Jeffrey L. Lennox,Carlos Franco-Paredes +11 more
TL;DR: Given the high prevalence of certain helminths and the potential lack of suggestive symptoms and signs, selected screening for strongyloidiasis and schistosomiasis or use of empirical antiparasitic therapy may be appropriate among foreign-born, HIV-infected patients.
Journal ArticleDOI
Predictors of Success with Highly Active Antiretroviral Therapy in an Antiretroviral-Naive Urban Population
TL;DR: In this paper, the authors analyzed predictive factors of successful virologic, immunologic, and clinical response with combined antiretroviral therapy (cART) containing a boosted protease inhibitor or a non-nucleoside reverse transcriptase inhibitor.